Natixis’s Omega Healthcare OHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.8M | Buy |
331,626
+331,577
| +676,688% | +$15.4M | 0.06% | 209 |
|
|
2026
Q1 | $2.15K | Buy |
+49
| New | +$2.24K | ﹤0.01% | 1053 |
|
|
2025
Q4 | – | Sell |
-41,277
| Closed | -$1.74M | – | 1247 |
|
|
2025
Q3 | $1.74M | Buy |
+41,277
| New | +$1.66M | 0.01% | 589 |
|
|
2025
Q2 | – | Sell |
-26,612
| Closed | -$1.02M | – | 1128 |
|
|
2025
Q1 | $1.02M | Buy |
26,612
+4,697
| +21% | +$175K | 0.01% | 551 |
|
|
2024
Q4 | $829K | Buy |
21,915
+5,416
| +33% | +$216K | 0.01% | 631 |
|
|
2024
Q3 | $672K | Buy |
+16,499
| New | +$624K | ﹤0.01% | 592 |
|
|
2023
Q3 | – | Sell |
-166,600
| Closed | -$5.11M | – | 1099 |
|
|
2023
Q2 | $5.11M | Buy |
+166,600
| New | +$4.81M | 0.04% | 292 |
|
|
2023
Q1 | – | Sell |
-79,885
| Closed | -$2.23M | – | 1138 |
|
|
2022
Q4 | $2.23M | Sell |
79,885
-16,915
| -17% | -$510K | 0.01% | 518 |
|
|
2022
Q3 | $2.85M | Sell |
96,800
-342,000
| -78% | -$10.7M | 0.01% | 524 |
|
|
2022
Q2 | $12.4M | Buy |
+438,800
| New | +$12.5M | 0.04% | 255 |
|
|
2022
Q1 | – | Sell |
-615,800
| Closed | -$18.2M | – | 1282 |
|
|
2021
Q4 | $18.2M | Buy |
615,800
+511,947
| +493% | +$14.9M | 0.06% | 260 |
|
|
2021
Q3 | $3.11M | Buy |
+103,853
| New | +$3.57M | 0.01% | 646 |
|
|
2020
Q4 | – | Sell |
-48,692
| Closed | -$1.46M | – | 1089 |
|
|
2020
Q3 | $1.46M | Buy |
+48,692
| New | +$1.52M | 0.01% | 467 |
|
|
2019
Q3 | – | Sell |
-8,211
| Closed | -$302K | – | 893 |
|
|
2019
Q2 | $302K | Sell |
8,211
-58,629
| -88% | -$2.14M | ﹤0.01% | 664 |
|
|
2019
Q1 | $2.55M | Buy |
+66,840
| New | +$2.48M | 0.02% | 475 |
|
|
2018
Q3 | – | Sell |
-7,805
| Closed | -$242K | – | 934 |
|
|
2018
Q2 | $242K | Sell |
7,805
-3,851
| -33% | -$110K | ﹤0.01% | 794 |
|
|
2018
Q1 | $307K | Buy |
11,656
+2,990
| +35% | +$79.7K | ﹤0.01% | 739 |
|
|
2017
Q4 | $239K | Sell |
8,666
-4,562
| -34% | -$132K | ﹤0.01% | 742 |
|
|
2017
Q3 | $422K | Buy |
13,228
+3,233
| +32% | +$104K | ﹤0.01% | 753 |
|
|
2017
Q2 | $330K | Sell |
9,995
-2,809
| -22% | -$92.9K | ﹤0.01% | 614 |
|
|
2017
Q1 | $422K | Buy |
12,804
+4,609
| +56% | +$148K | 0.01% | 557 |
|
|
2016
Q4 | $256K | Buy |
+8,195
| New | +$253K | ﹤0.01% | 705 |
|
Other funds holding OHI
Natixis's OHI Position: Q2 2026 in Review
Natixis increased its Omega Healthcare (OHI) stake by 676,688% in Q2 2026, buying an estimated $15.4M and bringing the position to 331,626 shares worth $15.8M. The position accounts for 0.06% of the portfolio, ranked #209.
Natixis first reported a position in OHI in Q4 2016 and has held it in 22 quarters since. The position peaked at $18.2M in Q4 2021. 761 funds tracked by Wall St. Rank hold OHI as of Q2 2026.
- Natixis held 331,626 shares of Omega Healthcare worth $15.8M as of Q2 2026.
- Natixis bought 331,577 Omega Healthcare shares in Q2 2026, an estimated $15.4M.
- Omega Healthcare made up 0.06% of Natixis's portfolio in Q2 2026, its #209 holding.
- Natixis first reported a position in Omega Healthcare in Q4 2016 and has held it in 22 quarters since.
- Natixis's Omega Healthcare position peaked at $18.2M in Q4 2021.
- 761 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.
Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.